D. E. Shaw & Co., Inc. Essa Pharma Inc. Call Options Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EPIX
# of Institutions
35Shares Held
35.1MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$15.8 Million1.69% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.88MShares$14.3 Million0.8% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$7.76 Million2.21% of portfolio
-
Morgan Stanley New York, NY4.18MShares$7.57 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.9 Million0.32% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $79.8M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...